Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 460 (C) , 24-35
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (AIRC)Associazione Italiana per la Ricerca sul Cancro
- Epigen grant of the Italian National Research Council (CNR)
- MOVIE project of the Regione Campania
- NIH (DK-15070)
- NIH (CA-50706)
This publication has 61 references indexed in Scilit:
- Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancerOncogene, 2011
- Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote TumorigenesisMolecular Cell, 2011
- Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in miceProceedings of the National Academy of Sciences, 2011
- The DNA Damage Response: Making It Safe to Play with KnivesMolecular Cell, 2010
- Senescence in tumours: evidence from mice and humansNature Reviews Cancer, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replicationNature, 2006
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005